Skip to main content

and
  1. Article

    Open Access

    Distinct patterns of disease activity over time in patients with active SLE revealed using latent class trajectory models

    Systemic lupus erythematosus (SLE) is a heterogeneous systemic autoimmune condition for which there are limited licensed therapies. Clinical trial design is challenging in SLE due at least in part to imperfect...

    John A. Reynolds, Jennifer Prattley, Nophar Geifman in Arthritis Research & Therapy (2021)

  2. Article

    Open Access

    Correction to: The effect of glucocorticoid therapy on mortality in patients with rheumatoid arthritis and concomitant type II diabetes: a retrospective cohort study

    An amendment to this paper has been published and can be accessed via the original article.

    Ruth E. Costello, Antonia Marsden, Mohammad Movahedi, Mark Lunt in BMC Rheumatology (2021)

  3. Article

    Open Access

    Harnessing repeated measurements of predictor variables for clinical risk prediction: a review of existing methods

    Clinical prediction models (CPMs) predict the risk of health outcomes for individual patients. The majority of existing CPMs only harness cross-sectional patient information. Incorporating repeated measurement...

    Lucy M. Bull, Mark Lunt, Glen P. Martin, Kimme Hyrich in Diagnostic and Prognostic Research (2020)

  4. Article

    Open Access

    A review of the use of propensity score diagnostics in papers published in high-ranking medical journals

    Propensity scores are widely used to deal with confounding bias in medical research. An incorrectly specified propensity score model may lead to residual confounding bias; therefore it is essential to use diag...

    Emily Granger, Tim Watkins, Jamie C. Sergeant in BMC Medical Research Methodology (2020)

  5. Article

    Open Access

    The effect of glucocorticoid therapy on mortality in patients with rheumatoid arthritis and concomitant type II diabetes: a retrospective cohort study

    Patients with rheumatoid arthritis (RA) have increased cardiovascular (CV) and mortality risk. Patients with RA are also frequently prescribed glucocorticoids (GCs) which have been associated with increased ri...

    Ruth E. Costello, Antonia Marsden, Mohammad Movahedi, Mark Lunt in BMC Rheumatology (2020)

  6. Article

    Open Access

    P142 Androgen Receptor Reduced Sensitivity is Associated with Cardiovascular Mortality in Men with Type 2 Diabetes - A 14-year Follow up Study

    Hypogonadism associates with increased cardiovascular morbidity/mortality in type 2 diabetes mellitus (T2DM) [1]. Increasing CAG repeat number within exon 1 of the androgen receptor gene associates with increased...

    Adrian Heald, Ghasem Yadegarfar, Mark Livingston, Helene Fachim in Artery Research (2019)

  7. Article

    Open Access

    How the weather affects the pain of citizen scientists using a smartphone app

    Patients with chronic pain commonly believe their pain is related to the weather. Scientific evidence to support their beliefs is inconclusive, in part due to difficulties in getting a large dataset of patient...

    William G. Dixon, Anna L. Beukenhorst, Belay B. Yimer, Louise Cook in npj Digital Medicine (2019)

  8. Article

    Open Access

    Social deprivation modifies the association between incident foot ulceration and mortality in type 1 and type 2 diabetes: a longitudinal study of a primary-care cohort

    The aim of this study was to determine whether social deprivation in the presence of diabetes is an independent predictor of develo** a foot ulcer and separately of mortality.

    Simon G. Anderson, Haika Shoo, Sushant Saluja, Christian D. Anderson in Diabetologia (2018)

  9. Article

    Open Access

    Use and effectiveness of tocilizumab among patients with rheumatoid arthritis: an observational study from the British Society for Rheumatology Biologics Register for rheumatoid arthritis

    The aims of the present study are to describe the characteristics of rheumatoid arthritis (RA) patients selected for tocilizumab (TCZ), compare the “real-world” effectiveness of TCZ and tumour necrosis factor ...

    Mari Kihara, Rebecca Davies, Lianne Kearsley-Fleet, Kath D. Watson in Clinical Rheumatology (2017)

  10. Article

    Open Access

    Oral glucocorticoid therapy and all-cause and cause-specific mortality in patients with rheumatoid arthritis: a retrospective cohort study

    Previous studies of glucocorticoid (GC) therapy and mortality have had inconsistent results and have not considered possible perimortal bias—a type of protopathic bias where illness in the latter stages of lif...

    Mohammad Movahedi, Ruth Costello, Mark Lunt in European Journal of Epidemiology (2016)

  11. Article

    Open Access

    Half of UK patients with rheumatoid arthritis are prescribed oral glucocorticoid therapy in primary care: a retrospective drug utilisation study

    Patients with rheumatoid arthritis (RA) have shared care between rheumatologists and general practitioners (GPs). Rheumatologists guide immunosuppressive therapy, whilst GPs rely on analgesia and glucocorticoi...

    Rachel J. Black, Rebecca M. Joseph, Benjamin Brown in Arthritis Research & Therapy (2015)

  12. No Access

    Article

    Risk of birth defects associated with maternal pregestational diabetes

    Maternal diabetes preceding pregnancy may increase the risk of birth defects in the offspring, but not all studies confirm this association, which has shown considerable variation over time, and the effect of ...

    Marco Vinceti, Carlotta Malagoli, Kenneth J. Rothman in European Journal of Epidemiology (2014)

  13. Article

    Open Access

    Investigation of Caucasian rheumatoid arthritis susceptibility loci in African patients with the same disease

    The largest genetic risk to develop rheumatoid arthritis (RA) arises from a group of alleles of the HLA DRB1 locus ('shared epitope', SE). Over 30 non-HLA single nucleotide polymorphisms (SNPs) predisposing to di...

    Sebastien Viatte, Edward Flynn, Mark Lunt, Joanne Barnes in Arthritis Research & Therapy (2012)

  14. Article

    Open Access

    Correlation of C-reactive protein haplotypes with serum C-reactive protein level and response to anti-tumor necrosis factor therapy in UK rheumatoid arthritis patients: results from the Biologics in Rheumatoid Arthritis Genetics and Genomics Study Syndicate cohort

    In many European countries, restrictions exist around the prescription of anti-tumor necrosis factor (anti-TNF) treatments for rheumatoid arthritis (RA). Eligibility and response to treatment is assessed by us...

    Darren Plant, Ibrahim Ibrahim, Mark Lunt, Stephen Eyre in Arthritis Research & Therapy (2012)

  15. Article

    Open Access

    Seropositivity is associated with insulin resistance in patients with early inflammatory polyarthritis: results from the Norfolk Arthritis Register (NOAR): an observational study

    Cardiovascular disease (CVD) is the leading cause of death in patients with inflammatory polyarthritis (IP), especially in seropositive disease. In established rheumatoid arthritis (RA), insulin resistance (IR...

    Hoda Mirjafari, Tracey M Farragher, Suzanne MM Verstappen in Arthritis Research & Therapy (2011)

  16. Article

    Open Access

    Exploring the validity of estimating EQ-5D and SF-6D utility values from the health assessment questionnaire in patients with inflammatory arthritis

    Utility scores are used to estimate Quality Adjusted Life Years (QALYs), applied in determining the cost-effectiveness of health care interventions. In studies where no preference based measures are collected,...

    Mark J Harrison, Mark Lunt, Suzanne MM Verstappen in Health and Quality of Life Outcomes (2010)

  17. No Access

    Article

    Changes in bone mineral density in the hip and spine before, during, and after the menopause in elite runners

    This study was undertaken to determine the degree of interaction between hormonal and athletic effects on changes in bone mineral density (BMD, g/cm2) with time in women around the menopause. Thirty-five elite fe...

    Alexandra Tomkinson, Jane H. Gibson, Mark Lunt, Mark Harries in Osteoporosis International (2003)